Biobanking Market by Product and Service(Equipment, Consumables,
Services, Software), Sample Type (Blood Products, Human Tissues,
Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life
Science, Clinical Research) - Global Forecast to 2022
The Biobanking Market is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in
2017, at a CAGR of 7.8%.
According to the new market research report "Biobanking Market by Product and
Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human
Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical
Research) - Global Forecast to 2022" published by MarketsandMarkets™.
Factors driving the growth of this market include the increasing number of genomics research
activities for studying diseases; advances in biobanking and the growing trend of conserving
cord blood stem cells of newborns; government & private funding to support regenerative
medicine research; and the growing need for cost-effective drug discovery and development.
Don’t miss out on business opportunities in Biobanking Market.
The equipment segment is expected to dominate the market in 2017
By product and service, the Biobanking Market is segmented into equipment, consumables,
services, and software. The equipment segment is expected to dominate the global Biobanking
Market in 2017. Rising number of biobanks and the increasing number of biospecimens are
factors increasing the demand for biobanking equipment.